James Anthony Datin Insider Profile
4 Followers
James Anthony Datin, Director at Quantum Biopharma, holds 98.96K shares in Quantum Biopharma (Ticker: QNTM).
James Anthony Datin's Trading History
| QNTMQuantum Biopharma | Feb 23, 2021 | Director | Uninformative Buy | 100.00K | $142.50K | ||||||||||||||||||||||||||||||||||||
QNTM Insider Shares: 98.96K (51.65%)
| |||||||||||||||||||||||||||||||||||||||||
You May Also Like
James Anthony Datin insider profile FAQ
What is the percentage of profitable transactions made by James Anthony Datin?
The percentage of profitable transactions made by James Anthony Datin is 0%.
What is the average return per transaction made by James Anthony Datin?
The average return per transaction made by James Anthony Datin is -44.00%.
What stocks does James Anthony Datin hold?
James Anthony Datin holds: QNTM stocks.
What was James Anthony Datin’s latest transaction?
James Anthony Datin’s latest transaction was an Uninformative Buy of $100.00K.
What was James Anthony Datin's most profitable transaction?
James Anthony Datin’s most profitable transaction was an Informative Buy of QNTM stock on March 21, 2020. The return on the trade was -15.30%.
What is James Anthony Datin's role in Quantum Biopharma?
James Anthony Datin's role in Quantum Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
